Aytu BioScience, Inc.
- Targets
- 1
- Filings
- 1
- Median premium
- 109%
- First filing
- Feb 9, 2021
- Latest filing
- Feb 9, 2021
Targets
| Company | Score before deal | Score now | Filings | Latest |
|---|---|---|---|---|
| Neos Therapeutics, Inc. | — | — | 1 | Feb 9, 2021 |
Deal filings
| Filed | Company | Form | Price | Premium |
|---|---|---|---|---|
| Feb 9, 2021 | Neos Therapeutics, Inc. | DEFM14A | $0.11 | 108.8% |